(Press-News.org) Toronto, ON, December 11, 2025 – Annual prescriptions for drugs to treat attention-deficit/hyperactivity disorder (ADHD) increased 157 percent in Ontario from 2015 to 2023, according to a new study from researchers at ICES, North York General, and The Hospital for Sick Children (SickKids).
ADHD is a common neurodevelopmental disorder that affects approximately 1.6 to 5 percent of people worldwide. Stimulant medications such as amphetamines are often prescribed to treat the symptoms of ADHD and can lead to improvements in health and social outcomes in people with ADHD.
“The upward trend in prescriptions around the world highlights an important challenge,” says Dr. Daniel Myran, a family physician, ICES scientist, and Research Chair in Family and Community Medicine at North York General. “On one hand, it is likely showing progress towards identifying and treating ADHD in groups who have historically been underdiagnosed. However, the size of the increases also raises concerns about mis- or over-diagnosis, which can result in exposure to adverse side effects of medications and a missed opportunity to treat other mental health conditions.”
The study included over 15 million people aged 5 to 105 years old living in Ontario, Canada, and found that 591,224 individuals (4 percent) had one or more stimulant prescriptions.
Key findings:
Overall annual new stimulant prescriptions increased by 157.2 percent, from 275 per 100,000 individuals in 2015 to 708 in 2023.
Stimulant prescriptions accelerated in 2020, increasing 28 percent per year between 2020 and 2023, compared to only 7 percent from 2015 to 2019.
Stimulant prescriptions increased much more in women and in those aged 18-44. Over the study, stimulant prescriptions increased by 421.3% and 368.7% in females aged 25-44 and 18-24 respectively.
Greater increases in stimulant prescribing in females resulted in the prevalence in females exceeding that of males for many age groups. By the end of the study, 6.7% of females aged 18-24 had one or more stimulant prescriptions in the past year compared to 5.2% of males.
One of the limitations of the study was a lack of data on whether the medication was being prescribed appropriately.
The authors suggest several explanations for the increase in stimulant prescribing. First, that there has been a true rise in the number of individuals with symptoms of ADHD or ADHD, possibly related to changing social and environmental conditions such as greater use of screens and online content engagement for work and recreation. Second, improvement in the identification of undiagnosed ADHD, particularly in groups historically less recognized for ADHD. Third, misdiagnosis or overdiagnosis.
“The acceleration in 2020 coincides with the COVID-19 pandemic during which there was a large increase in online content about adult ADHD diagnoses and the emergence of private virtual clinics offering rapid ADHD assessments, says Myran. “These changes may both increase awareness and reduce barriers to diagnosis for people who have ADHD, but also increase the risk of overdiagnosis.”
“With around seven per cent of children and a nearly three-fold increase in adults being prescribed stimulants for ADHD than before the pandemic, ongoing research and clear clinical guidance are essential to ensuring these medications are used safely and appropriately,” says Dr. Yaron Finkelstein, Staff Physician, Senior Scientist in the Child Health Evaluative Sciences program, Canada Research Chair in Pediatric Drug Safety and Efficacy, and the study’s senior author.
ICES is an independent, not-for-profit research and analytics institute that uses population-based health information to produce knowledge on a broad range of healthcare issues. ICES leads cutting-edge studies and analyses evaluating healthcare policy, delivery, and population outcomes. Our knowledge is highly regarded in Canada and abroad and is widely used by government, hospitals, planners, and practitioners to make decisions about healthcare delivery and to develop policy. For the latest ICES news, follow us on BlueSky and LinkedIn: @ICESOntario
The Hospital for Sick Children (SickKids) has been changing the game for paediatric health care since it became the first children’s hospital in Canada in 1875. Affiliated with the University of Toronto, SickKids is one of Canada’s most research-intensive hospitals and has generated discoveries that have helped children globally. Its mission is to provide the best in complex and specialized care; promote a culture centred around patient and family experience; pioneer scientific and clinical advancements; foster an academic environment that nurtures health-care professionals; and champion an accessible, comprehensive and sustainable child health system. In 2025, SickKids is celebrating 150 years of excellence in children's health, continuing to advance Precision Child Health, its groundbreaking movement to deliver individualized care, including responsibly using artificial intelligence to improve clinical care and research. SickKids is proud of its vision for Healthier Children. A Better World. For more information, please visit www.sickkids.ca.
North York General is one of Canada’s leading community academic hospitals with a vision to deliver World-Class Care, 24/7. Affiliated with the University of Toronto, our multi-site campus supports our diverse community through every stage and life-defining moment by providing a wide range of acute care, ambulatory and long-term care services.
North York General is a member of the North York Toronto Health Partners, an Ontario Health Team that integrates local care with patients, primary care and community partners.
FOR FURTHER INFORMATION PLEASE CONTACT:
Charlotte Lam
Communications Associate, ICES
media@ices.on.ca
437-317-8804
END
ADHD prescriptions on the rise, study finds
2025-12-11
ELSE PRESS RELEASES FROM THIS DATE:
How to build a genome
2025-12-11
Leading synthetic biologists have shared hard-won lessons from their decade-long quest to build the world's first synthetic eukaryotic genome in a Nature Biotechnology paper out today. Their insights could accelerate development of the next generation of engineered organisms, from climate-resilient crops to custom-built cell factories.
"We've assembled a comprehensive overview of the literature on how to build a life form where we review what went right – but also what went wrong," says Dr Paige Erpf, lead author of the paper and postdoctoral researcher at Macquarie University's School of Natural Sciences and the Australian ...
Sharp rise in ADHD stimulant prescriptions in Ontario, research finds
2025-12-11
A new Ontario-based study has found a significant rise in prescriptions for stimulant medications used to treat attention-deficit/hyperactivity disorder (ADHD), particularly among adults and females. The study, published in JAMA Network Open, calls for better clinical guidance to help ensure those medications are prescribed appropriately, and to help prevent possible adverse health effects, such as heart conditions.
ADHD is a common neurodevelopmental condition that affects attention and impulse control, impacting about five per cent of the population.
Researchers from The ...
Trends and prevalence of the metabolic syndrome among US adults
2025-12-11
About The Study: As of 2023, approximately one-third of U.S. adults met criteria for metabolic syndrome, with overall prevalence showing no significant change between 2013 and 2023. Even though most individual metabolic syndrome components remained largely stable over the past decade, elevation in triglycerides demonstrated a modest increase.
Corresponding Author: To contact the corresponding author, Shady Abohashem, MD, MPH, email sabohashem@mgh.harvard.edu.
To access the embargoed study: Visit our For The Media website ...
Population-level trends in ADHD medication prescribing
2025-12-11
About The Study: This population-based, repeated cross-sectional study identified increases in stimulant prescribing, accelerating in 2020, particularly among females and individuals ages 18 to 64. The findings are consistent with prior research in commercially insured U.S. populations; however, this population-wide study reveals a broader and more accelerated increase in stimulant prescribing.
Corresponding Author: To contact the corresponding author, Daniel T. Myran, MD, MPH, email dmyran@ohri.ca.
To access the embargoed study: Visit our For The ...
Missing piece of myelin disturbs the brain’s rhythm
2025-12-11
Our nerve cells are surrounded by a protective layer (myelin). This protective layer allows signals to pass between cells incredibly quickly. But what happens when this layer goes missing from cells that transfer signals over longer distances? Maarten Kole’s research group studied this question in mice, looking specifically at nerve fibres travelling from the brain’s outer layer to the thalamus, a crucial switching station deep in the middle of the brain.
Processing sensory information involves continuous communication between the brain’s outer layer (cerebral cortex) and the thalamus. Such an exchange, for example, ...
Insilico Medicine and Taigen achieves license agreement to develop and commercialize AI-driven PHD inhibitor for anemia of Chronic Kidney Disease (CKD)
2025-12-11
Insilico Medicine has licensed TaiGen Biotechnology exclusive rights in the Greater China area to develop, commercialize, and sub-license ISM4808, an AI-driven potential best-in-class oral PHD inhibitor with IND clearance granted in 2023.
The partnership combines Insilico’s generative AI discovery platform with TaiGen’s regional clinical and commercial expertise to accelerate the development of ISM4808 for the treatment of Anemia of Chronic Kidney Disease (CKD).
Shanghai and Taipei, December 12, 2025 --- Insilico ...
Exploring dominant endophytic Pleosporales in grasses: New taxonomic insights in the suborder Massarineae
2025-12-11
A research team led by Professor Chulong Zhang at the College of Agriculture and Biotechnology, Zhejiang University, China, investigated dominant endophytic fungi of the order Pleosporales isolated from Poaceae plants collected in Yunnan, Zhejiang, and Inner Mongolia, China. The study, published in Mycology, combined multi-locus phylogenetic analyses with morphological observations to resolve taxonomy and species limits among key pleosporalean endophytes of grasses.
The analysis confirmed that the family Didymosphaeriaceae forms a strongly supported monophyletic group. Within this lineage, the researchers identified multiple well-supported clades corresponding ...
Comparative transcriptomic analysis of human maxillary and mandibular tooth germs reveals discrepancies in gene expression patterns
2025-12-11
The interaction between genetics and tissue environment shapes how individual teeth form in different regions of the jaw. While most experimental studies have focused on mandibular (lower jaw) teeth, little was known about how human maxillary (upper jaw) and mandibular teeth diverge at the molecular level during early development.
In a new study published in Oral Science and Homeostatic Medicine, a collaborative team from Beijing Stomatological Hospital, Capital Medical University, and Peking University School and Hospital of Stomatology performed a RNA-sequencing analysis of human fetal tooth germs at the cap stage (11–12 post-conception ...
Scientists detect atmosphere on molten rocky exoplanet - study
2025-12-11
Researchers using NASA’s James Webb Space Telescope have detected the strongest evidence yet for an atmosphere on a rocky planet outside our solar system.
Observations of the ultra-hot super-Earth TOI-561 b suggest the exoplanet is surrounded by a thick blanket of gases above a global magma ocean.
Publishing their findings today (11 Dec) in The Astrophysical Journal Letters, researchers say that the results help to explain the planet’s unusually low density and challenge the prevailing wisdom that relatively small planets so close ...
Chip-scale magnetometer uses light for high-precision magnetic sensing
2025-12-11
WASHINGTON — Researchers have developed a precision magnetometer based on a special material that changes optical properties in response to a magnetic field. The device, which is integrated onto a chip, could benefit space missions, navigation and biomedical applications.
High-precision magnetometers are used to measure the strength and direction of magnetic fields for various applications. However, many of today’s magnetometers must operate at extremely low temperatures — close to 0 kelvin — or require relatively large and heavy apparatus, which significantly restricts their practicality.
“Our device operates at room temperature and can be fully integrated ...